As the number of diagnosed cases of COVID-19 continues to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine and therapies for the respiratory infection that was declared a pandemic by the World Health Organization.

With more and more nations calling for self-quarantines due to the rapid spread of COVID-19 across the globe, companies are urging employees to work from home in order to decrease the spread of the virus.

The U.S. Food and Drug Administration granted Roche’s cobas SARS-CoV-2 Test Emergency Use Authorization.

As COVID-19 spreads across the globe, Vancouver-based AbCellera and Eli Lilly teamed up to co-develop antibody products for the treatment and prevention of the novel coronavirus.

Canada’s Medicago announced the successful production of a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 gene. The company is focused on developing a vaccine for COVID-19, the virus caused by SARS-CoV-2.

Canadian Prime Minister Justin Trudeau’s wife, Australia’s minister for home affairs and a Chelsea soccer player are among new cases of the coronavirus that has infected almost 135,000 people and killed more than 4,900 worldwide.

Part of the blame for limited testing availability for the coronavirus pandemic could fall squarely on the Centers for Disease Control (CDC), which used highly restrictive language in the health protection agency’s emergency use authorization for COVID-19 testing.

The United States is preparing for thousands of new coronavirus cases and will ask Americans returning from abroad to go into “self-quarantine” for 14 days as part of the effort to contain the outbreak, Vice President Mike Pence said.

The Trump administration secured commitments from top pharmaceutical companies to work together to develop a vaccine and treatments to fight the coronavirus.

A team of Abbott scientists identified a new subtype of the human immunodeficiency virus, called HIV-1 Group M, subtype L.